NCT04470479View on ClinicalTrials.gov

Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 1, 2005

Primary Completion Date

April 1, 2006

Study Completion Date

April 1, 2006

Conditions
Dry Eye
Interventions
DRUG

Pilocarpine Hydrochloride

Oral pilocarpine hydrochloride 5mg tablets were administered four times a day for 10 weeks to half the group of selected patients. The other half ingested placebo in the same way. At the end of this period and after two weeks of washing out the medications, the patients had to invert the treatments.

DRUG

Placebo

Placebo

Trial Locations (1)

01221010

Irmandade Santa casa de Misericórdia de São Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT04470479 - Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome | Biotech Hunter | Biotech Hunter